BullFrog AI Publishes Annual Letter to Shareholders, Highlights 2025 Progress.

martes, 30 de diciembre de 2025, 5:05 pm ET1 min de lectura
BFRG--

BullFrog AI Holdings has published its annual letter to shareholders, highlighting progress made in 2025 and outlining commercial priorities and potential catalysts for 2026. The company has made significant strides in drug development using AI and machine learning, and the letter discusses key accomplishments and future plans. BullFrog AI is a technology-enabled drug development company listed on NASDAQ under the ticker symbols BFRG and BFRGW.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios